Anti-inflammatory effects of macrolides in childhood lung diseases.

Macrolides are drugs that have antimicrobial effects, especially against intracellular pathogens. Various studies have shown that macrolides might also have anti-inflammatory effects. Macrolides inhibit the production of interleukins and can reduce pulmonary neutrophilic inflammation. Clinical trials have demonstrated beneficial effects of macrolides in various chronic lung diseases. The objective of this study was to review recent data in the medical literature on the anti-inflammatory effects of macrolides in childhood lung diseases by searching the Medline (PubMed) database. We used the following search terms: "macrolide and cystic fibrosis"; "macrolide and asthma"; "macrolide and bronchiolitis obliterans"; and "macrolide and acute bronchiolitis". We selected articles published in international scientific journals between 2001 and 2012. Clinical studies and in vitro evidence have confirmed the anti-inflammatory effect of macrolides in respiratory diseases. Some clinical trials have shown the benefits of the administration of macrolides in patients with cystic fibrosis, although the risk of bacterial resistance should be considered in the analysis of those benefits. Such benefits are controversial in other respiratory diseases, and the routine use of macrolides is not recommended. Further controlled clinical trials are required in order to assess the efficacy of macrolides as anti-inflammatory drugs, so that the benefits in the treatment of each specific clinical condition can be better established.

• Publication year

  2012

• Venue

  Jornal Brasileiro de Pneumologia

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1590/S1806-37132012000600016PMID 23288126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.

  2012cited by this paper
• Open‐label, follow‐on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa

  2012cited by this paper
• Macrolides in the treatment of asthma

  2012cited by this paper
• Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial.

  2012cited by this paper
• Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.

  2012cited by this paper
• Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients

  2012cited by this paper
• Clarithromycin therapy for patients with Cystic Fibrosis: A randomized controlled trial

  2012cited by this paper
• Macrolide antibiotics for cystic fibrosis.

  2012cited by this paper
• Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study

  2011cited by this paper
• Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases

  2011cited by this paper
• Azithromycin Inhibits IL-5 Production of T Helper Type 2 Cells from Asthmatic Children

  2011cited by this paper
• Macrolide antibiotics for cystic fibrosis.

  2011cited by this paper
• The sentinel role of the airway epithelium in asthma pathogenesis

  2011cited by this paper
• Antibiotics for bronchiolitis in children.

  2011cited by this paper
• Fluticasone, Azithromycin, And Montelukast (FAM) Therapy In Reducing Corticosteroid Exposure In Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplant – A Case Series Of Eight Patients

  2010cited by this paper
• Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes.

  2010cited by this paper
• Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

  2010cited by this paper
• Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.

  2010cited by this paper
• Viruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic review

  2010cited by this paper
• Chronic macrolide therapy in inflammatory airways diseases.

  2010cited by this paper
• Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis

  2010cited by this paper
• Post infectious bronchiolitis obliterans in children.

  2010cited by this paper
• [Postinfectious bronchiolitis obliterans].

  2009cited by this paper
• Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma.

  2009cited by this paper
• Macrolides in the treatment of bronchiolitis obliterans in allograft recipients

  2009cited by this paper
• Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

  2008cited by this paper
• Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial

  2008cited by this paper
• Azithromycin Selectively Reduces Tumor Necrosis Factor Alpha Levels in Cystic Fibrosis Airway Epithelial Cells

  2007cited by this paper
• Daily versus weekly azithromycin in cystic fibrosis patients

  2007cited by this paper
• Macrolides in cystic fibrosis.

  2007cited by this paper
• Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis

  2006cited by this paper
• Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.

  2006cited by this paper
• Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

  2006cited by this paper
• Macrolide antibiotics and asthma treatment.

  2006cited by this paper
• Bronchiolitis.

  2006cited by this paper
• Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial

  2006cited by this paper
• Macrolides and airway inflammation in children.

  2005cited by this paper
• Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study

  2005cited by this paper
• Antibiotic-induced apoptosis in human activated peripheral lymphocytes.

  2005cited by this paper
• Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.

  2005cited by this paper
• Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium.

  2005cited by this paper
• Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.

  2004cited by this paper
• Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.

  2004cited by this paper
• Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.

  2004cited by this paper
• [Azithromycin therapy in cystic fibrosis].

  2004cited by this paper
• Immunomodulatory effects of macrolides in the lung: lessons from in-vitro and in-vivo models.

  2004cited by this paper
• Tratamiento con azitromicina en la fibrosis quística

  2004cited by this paper
• Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils.

  2004cited by this paper
• Azithromycin for cystic fibrosis

  2004cited by this paper
• In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells.

  2003cited by this paper
• Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

  2003cited by this paper
• [Upper airway cellular pattern in infants with acute bronchiolitis: neutrophils or eosinophils?].

  2003cited by this paper
• Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.

  2002cited by this paper
• Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.

  2002cited by this paper
• Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial

  2002cited by this paper
• Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: A pilot study *

  2001cited by this paper
• Anti‐inflammatory effects of macrolides in lung disease *

  2001cited by this paper
• Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro.

  2000cited by this paper
• Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells.

  2000cited by this paper
• Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

  1994cited by this paper

• Case report: Idiopathic subglottic stenosis in a girl; successful treatment with macrolides

  2022cites this paper
• Role of long-term azithromycin therapy for severe bronchial asthma

  2020cites this paper
• Effects of clarithromycin on inflammatory markers and clinical manifestations in postsurgical follow-up of patients with endometriosis: a double-blinded randomized placebo-controlled clinical trial

  2019cites this paper
• Lysosomotropic cationic amphiphilic drugs inhibit adipocyte differentiation in 3T3‐L1K cells via accumulation in cells and phospholipid membranes, and inhibition of autophagy

  2018cites this paper
• Burden of asthma among inner-city children from Southern Brazil

  2016cites this paper
• Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment

  2015cites this paper
• Rinossinusite crônica e polipose nasossinusal na fibrose cística: atualização sobre diagnóstico e tratamento* Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment

  2015cites this paper
• Macrolide therapy in cryptogenic organizing pneumonia: A case report and literature review

  2015cites this paper
• Follicular bronchiolitis in primary ciliary dyskinesia.

  2014cites this paper
• Desenvolvimento de métodos de extração de resíduos de antimicrobianos e quantificação em amostras alimentares

  2014cites this paper
• A review on guidelines for management and treatment of common variable immunodeficiency

  2013cites this paper